Skip to main content
  • Other Publications
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
  • COVID-19/SARS/MERS Articles
  • Info
  • Editors
  • Submit
  • Subscribe
  • More
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites.

A Iwasaki, C A Torres, P S Ohashi, H L Robinson and B H Barber
J Immunol July 1, 1997, 159 (1) 11-14;
  • Article
  • Info & Metrics
  • PDF

Abstract

Although plasmid DNA immunization provides an effective means of inducing CTL responses to an expressed Ag, the mechanism by which CTL precursors are activated remains to be established. Insights could be gained by identifying the cells responsible for Ag presentation when DNA is introduced into different tissue sites. By immunizing parent into F1 bone marrow chimeric mice with an influenza nucleoprotein-expressing plasmid, we have demonstrated that the key cells in this presentation process for both gene gun-mediated epidermal injection and needle intramuscular injection of plasmid DNA are bone marrow derived. Furthermore, as assessed by intramuscular injection, coexpression of nucleoprotein with the costimulatory molecule B7-2, or the cytokines granulocyte-macrophage CSF and IL-12, did not convert nonhemopoietic cells into APCs. Thus, for two distinctly different modes of DNA immunization, in one case with or without coexpressed immunostimulatory factors, the APCs were consistently found to be of hemopoietic origin.

  • Copyright © 1997 by American Association of Immunologists

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

Log in using your username and password

Forgot your user name or password?

We recommend

  1. Cross-priming as a predominant mechanism for inducing CD8(+) T cell responses in gene gun DNA immunization.
    J H Cho et al., J Immunol, 2001
  2. In vivo priming by DNA injection occurs predominantly by antigen transfer.
    M Corr et al., J Immunol, 1999
  3. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines.
    A Iwasaki et al., J Immunol, 1997
  4. Granulocyte-macrophage colony-stimulating factor-based melanoma cell vaccines immunize syngeneic and allogeneic recipients via host dendritic cells.
    Achim Schneeberger et al., J Immunol, 2003
  5. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.
    A Kuhöber et al., J Immunol, 1996
  1. CD4+ T-cell killing of multiple myeloma cells is mediated by resident bone marrow macrophages
    Haabeth, Blood Advances, 2020
  2. Enhancing immunotherapy of STING agonist for lymphoma in preclinical models
    Adrienne Sallets et al., Blood Advances, 2018
  3. Assessment of Safety and Immunogenicity of PVX-410 Vaccine With or Without Lenalidomide in Patients With Smoldering Multiple Myeloma: A Nonrandomized Clinical Trial
    Ajay K. Nooka et al., JAMA Oncology, 2018
  4. More than just a platelet factory
    Christopher G. Kanakry, Sci Transl Med
  5. FDA Identifies a list of 223 Most Needed Meds to Address Urgent Medical Conditions
    MRP, 2020
Powered by
PreviousNext
Back to top

In this issue

The Journal of Immunology
Vol. 159, Issue 1
1 Jul 1997
  • Table of Contents
  • Table of Contents (PDF)
Download PDF
Article Alerts
Email Article
Citation Tools
Share

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.